MedPath

The Gentle Cardiac Rehabilitation Study

Not Applicable
Completed
Conditions
Secondary Prevention of Coronary Heart Disease
Interventions
Behavioral: LITE
Behavioral: PLUS
Registration Number
NCT02165254
Lead Sponsor
The Miriam Hospital
Brief Summary

The purpose of this study is to develop a tai-chi based exercise program designed for patients who recently had a heart attack and do not wish, or are unable, to attend traditional cardiac rehabilitation.

Detailed Description

We will estimate the feasibility, acceptability and safety of two different doses of the Tai Chi intervention (primary outcome). 60 patients (30 per dose arm) will be randomly assigned to a standard dose of Tai Chi (the dose used by our group in large studies of heart failure patients) or to a high dose matching the recommended frequency and duration of exercise classes in current CRs. Acceptability assessments will include surveys and focus groups to formally assess the impact of Tai Chi on facilitators and barriers to CRs in this population. We will also obtain estimates of effect sizes of each dose on accelerometry measured physical activity and on the proportion of patients achieving the current American Heart Association (AHA) recommendation for physical activity (secondary outcome). Additional outcomes will be cardiac fitness, quality of life, body weight, and sleep. In addition, we will gather exploratory information on possible mechanisms by which Tai Chi training may affect physical activity. We will collect information on possible mediators such as exercise self-efficacy, perceived social support, and depression. In addition, since Tai Chi training is associated with meditative practices aimed at increasing present-moment awareness, we will gather information on mindfulness levels. Measurements will be conducted at baseline, 3-, 6-, and 9 months after enrollment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
33
Inclusion Criteria
  1. Able to understand and speak English
  2. Age ≥21
  3. Physically inactive
  4. Ability to understand the study procedures and willingness to commit to the demands of the study protocol
Exclusion Criteria
  1. Inability or unwillingness to give informed consent
  2. Planning to move out of the area within the study period
  3. Unstable angina
  4. Blood pressure >200/110 or symptomatic orthostatic blood pressure decrease>20 mmHg
  5. Uncontrolled atrial or ventricular arrhythmias; 3rd degree Atrio-Ventricular block
  6. Pericarditis or myocarditis
  7. Recent embolism/thrombophlebitis
  8. Abnormal stress test without study cardiologist's clearance
  9. Medical conditions likely to limit lifespan
  10. NYHA functional class IV
  11. Signs of cognitive impairment (BOMC >10)
  12. Orthopedic problems prohibiting Tai Chi practice
  13. Ongoing Tai Chi or other mind-body training
  14. Current enrollment in a CR program
  15. Severe depression (HADS scores>14)
  16. Current drug or alcohol use or dependence that would interfere with adherence to study requirements.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
standard dose tai chi interventionLITE-
high dose tai chi interventionPLUS-
Primary Outcome Measures
NameTimeMethod
retention ratesup to 9 months since enrollment
tai chi class attendance ratesup to 6 months since enrollment
number of participants with severe and non severe adverse eventsup to 9 months since enrollment
percentage of participants reporting intervention acceptability scores in highest quartile3, 6, and 9 months since enrollment
drop-out ratesup to 9 months since enrollment
Secondary Outcome Measures
NameTimeMethod
Mean between-group difference in within-participant change from baseline physical activity (accelerometry counts) over time (3, 6, and 9 months from enrollment)baseline, 3, 6, 9 months

To estimate mean between-doses differences in physical activity (and other continuous secondary outcomes listed below), we will estimate multivariate linear mixed models for within-participant change since baseline as a function of dose group (high or low), time point (3, 6, and 9 months from enrollment, treated as a categorical variable to allow for non-linear trajectories), and their interaction. A statistically significant interaction indicates that between-group differences vary across time points.

Trial Locations

Locations (1)

The Miriam Hospital

🇺🇸

Providence, Rhode Island, United States

© Copyright 2025. All Rights Reserved by MedPath